Exelixis Profit Margin

The latest profit margin for EX9.DE is 33.75% as of September 2026. That compares with 29.63% in the prior-year period — up 13.9% year over year. That is above the Healthcare sector average of 19.13%. Investors often review this figure alongside Exelixis's historical trend and sector peers before judging valuation or financial health.

Over the past year, EX9.DE's profit margin moved from 29.63% to 33.75% — a 13.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Exelixis's valuation or profitability profile.

Against Healthcare companies, EX9.DE currently prints 33.75% for profit margin, while the sector average sits near 19.13%. That is roughly 76.4% above the sector mean. Large gaps often invite a closer look at Exelixis's growth, margins, and balance sheet.

Profit Margin shows how effectively Exelixis converts resources into returns. At 33.75%, EX9.DE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 29.63% in the prior-year period — up 13.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting EX9.DE's profit margin (33.75%), review year-over-year change from 29.63%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.